LEADER 06773nam 2200721 a 450 001 9910957321103321 005 20251017110103.0 010 $a9786610185634 010 $a9780309172288 010 $a0309172284 010 $a9781280185632 010 $a1280185635 010 $a9780309593885 010 $a0309593883 010 $a9780585259901 010 $a0585259909 035 $a(CKB)110986584752908 035 $a(OCoLC)45731829 035 $a(CaPaEBR)ebrary10055159 035 $a(SSID)ssj0000196421 035 $a(PQKBManifestationID)12024615 035 $a(PQKBTitleCode)TC0000196421 035 $a(PQKBWorkID)10143756 035 $a(PQKB)10300347 035 $a(MiAaPQ)EBC3376165 035 $a(Au-PeEL)EBL3376165 035 $a(CaPaEBR)ebr10055159 035 $a(OCoLC)923261685 035 $a(Perlego)4736736 035 $a(DNLM)929577 035 $a(BIP)6397735 035 $a(EXLCZ)99110986584752908 100 $a19991227d2000 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aManaged care systems and emerging infections $echallenges and opportunities for strengthening surveillance, research, and prevention : workshop summary, based on a workshop of the Forum on Emerging Infections, Division of Health Sciences Policy, Institute of Medicine /$fJonathan R. Davis, editor 205 $a1st ed. 210 $aWashington, DC $cNational Academy Press$d2000 215 $a1 online resource (127 p.) 300 $aBibliographic Level Mode of Issuance: Monograph 311 08$a9780309068284 311 08$a0309068282 320 $aIncludes bibliographical references. 327 $aManaged Care Systems and Emerging Infections -- Copyright -- REVIEWERS -- Preface -- Contents -- Summary -- BASIC AND CLINICAL RESEARCH -- CLINICAL PRACTICE GUIDELINES -- SURVEILLANCE AND MONITORING -- EDUCATION AND OUTREACH -- DRUG FORMULARIES -- 1 Introduction -- BACKGROUND -- ABOUT THE WORKSHOP AND ORGANIZATION OF THE WORKSHOP SUMMARY -- 2 Conducting Basic and Clinical Research in the Managed Care Setting -- PERSPECTIVE OF ASSOCIATION OF AMERICAN MEDICAL COLLEGES ON BASIC AND CLINICAL RESEARCH -- OPPORTUNITIES FOR POPULATION-BASED CLINICAL RESEARCH USING DATA FROM MANAGED CARE ORGANIZATIONS -- CONDUCTING CLINICAL RESEARCH WITHIN MANAGED CARE ORGANIZATIONS -- NIH ACTIVITIES RELATED TO CLINICAL RESEARCH AND MANAGED CARE -- SUMMARY OF CHALLENGES AND OPPORTUNITIES -- Supporting the Functions of Academic Health Centers -- Ensuring Adequate Databases for Clinical Research -- Exploiting the Unique Advantages of Managed Care for Surveillance and Research -- Promoting Collaboration -- Summary -- 3 Clinical Practice Guidelines -- CLINICAL PRACTICE GUIDELINES FOR EMERGING INFECTIONS AND MANAGED CARE -- REALITIES OF IMPLEMENTING GUIDELINES -- MAKING GUIDELINES INSTRUMENTAL: THEORY VERSUS PRACTICE -- SUMMARY OF CHALLENGES AND OPPORTUNITIES -- Promoting Adoption and Use of Guidelines in Managed Care Organizations -- Involving Clinicians in Guideline Development and Implementation -- The Need for Systemwide, Standardized Guidelines -- Promoting Professional and Public Education -- Summary -- 4 Surveillance and Monitoring -- AN EMPLOYER'S PERSPECTIVE -- MANAGED CARE AND INFECTIOUS DISEASE SURVEILLANCE: OPPORTUNITIES FOR COLLABORATION -- COLLABORATIVE SURVEILLANCE EFFORTS AND MONITORING OF DATA -- LATTER DAY SAINTS HOSPITAL'S SYSTEM -- LABORATORY-BASED REPORTING AND MANAGING ENCOUNTER-LEVEL DATA -- LABORATORY-BASED REPORTING ISSUES -- LEGAL CONCERNS. 327 $aSUMMARY OF CHALLENGES AND OPPORTUNITIES -- Understanding Professional Roles in Surveillance and Monitoring -- Ensuring Availability of Data -- Promoting Sharing of Data -- Tracking Nosocomial Infections -- Accurate Reporting of Encounter-Level Data -- Overcoming Structural Barriers -- Summary -- 5 Education and Outreach -- COORDINATING HEALTH PLAN RESEARCH AND EDUCATIONAL EFFORTS -- IMPACTS OF MANAGED CARE SYSTEM'S EDUCATIONAL EFFORTS ON CONTROL OF ANTIBIOTIC USE -- EDUCATION AND OUTREACH PERSPECTIVES OF THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES -- MANAGED CARE SYSTEMS AND EMERGING INFECTIONS: EDUCATION AND OUTREACH -- SUMMARY OF CHALLENGES AND OPPORTUNITIES -- Promote Professional Education Efforts -- Encourage Judicious Antibiotic Use -- Invest in Educational Programs -- Summary -- 6 Drug Formularies -- REGULATORY ISSUES -- RELATIONSHIP BETWEEN MANAGED CARE FORMULARIES AND TREATMENT OUTCOMES -- BACTERIAL RESISTANCE, THE ANTIBIOTIC FORMULARY, AND OTHER MANAGEMENT STRATEGIES -- ECONOMICS OF RESTRICTIONS ON PHARMACEUTICALS -- SUMMARY OF CHALLENGES AND OPPORTUNITIES -- Ensuring Availability of Current Information on New Drugs -- Managing Antibiotic Selective Pressure -- Need for New Management Strategies for Cost Reduction -- Achieving Quality Care and Cost Containment -- Summary -- 7 Concluding Remarks -- References -- Appendix A Veterans Health Administration and Infectious Disease -- CLINICAL RESEARCH -- CLINICAL PRACTICE -- Information Technology -- Homelessness -- SURVEILLANCE AND MONITORING -- Emerging Pathogens Initiative -- Annual Infectious Diseases and Infection Control Report -- EDUCATION -- DRUG FORMULARY -- Appendix B Glossary and Acronyms -- Acronyms -- Glossary -- Appendix C Workshop Agenda -- Appendix D Forum Member and Staff Biographies -- FORUM MEMBERS -- STUDY STAFF. 330 $aManaged Care Systems and Emerging Infections: Challenges and Opportunities for Strengthening Surveillance, Research, and Prevention Jonathan R. Davis, Editor; Based on a Workshop of the Forum on Emerging Infections, Institute of Medicine This workshop summary report from the IOM Forum on Emerging Infections, Managed Care Systems and Emerging Infections: Challenges and Opportunities for Strenghening Surveillance, Research and Prevention This book examines how the managed care revolution has created both problems and opportunities in the fight against infectious diseases. It highlights ways in which managed care systems can aid research, develop clinical guidelines, manage the use of antibiotics, support public education efforts, and monitor the spread of emerging infections and microbial resistance. 606 $aEmerging infectious diseases 606 $aManaged care plans (Medical care) 615 0$aEmerging infectious diseases. 615 0$aManaged care plans (Medical care) 676 $a362.1/04258 701 $aDavis$b Jonathan R$01805450 712 02$aInstitute of Medicine (U.S.) 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910957321103321 996 $aManaged care systems and emerging infections$94360764 997 $aUNINA